Article
Benefits of reviewing pancreatic function in children with cystic fibrosis
2022-02-06
Abstract excerpt
<h4>Background: </h4> Cystic fibrosis is a common cause of pancreatic exocrine insufficiency. Clinically pancreatic insufficiency is treated as a permanent problem. However, new cystic fibrosis transmembrane conductance regulator (CFTR) protein modulator therapies, like ivacaftor, can change pancreatic function in children. Also, children with residual CFTR function mutations may be pancreatic insufficient in infa...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c68af209-dcad-5e98-beeb-259bcd1a4c8a
- DOI
- 10.22541/au.164410910.09290867/v1
